Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Molybdenum oxide nanozymes can effectively treat and monitor acute kidney injury by reducing oxidative stress.

EISA uses enzymes to create precise nanostructures in cells, offering new ways to design adaptive materials and therapies.

Geranium pyrenaicum extracts show potential for cancer, antiviral, and enzyme inhibition treatments.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Transglutaminases help form strong hair by linking proteins, and can potentially alter hair properties.

Finasteride affects UGT1A4 enzyme, but not enough to cause issues when combined with other drugs.

Adam10 enzyme is crucial for healthy skin and proper Notch signaling.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

Mutants of CYP154C2 enzyme significantly improved steroid conversion efficiency.

Cytochrome P-450 enzymes in the skin help break down various substances and could be targeted to treat skin conditions.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Some natural compounds from Iris plants can block enzymes related to certain disorders, with a few affecting both targeted enzymes.

Nanozymes show promise for effective and safe cancer treatment.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Cystatin M/E strongly inhibits cathepsin V and cathepsin L, important for skin formation.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Pharmacophore models can predict liver toxicity and central nervous system toxicity, but they have limitations and specific requirements.

A specially designed molybdenum oxide nanozyme can treat and monitor acute kidney injury effectively.

New tests detect finasteride and dutasteride in urine quickly and easily.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

A new nanoagent effectively kills bacteria and speeds up wound healing.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Procyanidin compounds from grape seeds were found to significantly increase mouse hair growth.